Hyperammonemia increases brain glutamine levels, causes astrocytic swelling, and depresses cerebral blood flow (CBF) responsivity to CO2. Methionine sulfoximine (MSO) inhibition of glutamine synthetase activity, known to be enriched in astrocytes, prevents ammonia-induced increases in brain glutamine and water content. We tested the hypothesis that inhibition of glutamine accumulation restores CBF responsivity to CO2 during acute hyperammonemia. Pentobarbital-anesthetized rats treated with either vehicle or MSO (150 mg/kg i.p.) received a 6-hour intravenous infusion of either sodium or ammonium acetate. With subsequent induction of hypercapnia, CBF increased from 113± 14 (mean±SEM) to 194±9 mIl/min per 100 g in control rats but was unchanged from 107±+13 to 79±10 ml/min per 100 g in hyperammonemic rats. Treatment with MSO in hyperammonemic rats restored the CBF response to hypercapnia (from 73±8 to 141±t14 ml/min per 100 g). With induction of hypocapnia, CBF decreased from 114+11 to 88± 11 ml/min per 100 g in control rats but increased from 112± 13 to 142± 19 ml/min per 100 g in hyperammonemic rats. Treatment with MSO in hyperammonemic rats did not fully restore the response to hypocapnia but prevented the paradoxical increase in CBF (from 80±8 to 80±8 ml/min per 100 g). In control rats, MSO did not affect CO2 responsivity. Treatment with MSO prevented ammonia-induced increases in intracranial pressure. Hyposmotic-induced increases in brain water content and intracranial pressure attenuated the CBF response to hypercapnia but, unlike hyperammonemia, did not attenuate the response to hypocapnia. In contrast to hypercapnia, vasodilation in response to arterial hypotension was intact in hyperammonemic rats. We conclude that the grossly abnormal CBF responsivity to CO2 alterations during hyperammonemia is linked to glutamine accumulation rather than ammonia per se. Cerebral edema secondary to glutamine accumulation may contribute in part to abnormal CBF responses, although other aspects of astrocyte dysfunction are likely to be
T he increase in cerebral blood flow (CBF) associated with hypercapnia is attenuated by acute hyperammonemia. This attenuation has been reported in both the dog' and cat2 and is prevalent in most regions of the brain. Moreover, the decrease in CBF associated with hypocapnia is abolished by acute hyperammonemia, and regions such as the midbrain can have a paradoxical increase in CBF. 1 Elevated intracranial pressure also has been observed during hyperammonemia3 and has been attributed to increased cerebral blood volume,4 increased cerebrospi- nal fluid (CSF) production,5 and cerebral edema. 6 The edema is thought to be confined to the astrocyte compartment because Alzheimer II astrocytosis is a common feature of pure hyperammonemia,3,7 of hyperammonemia associated with liver disease,8 and of cultured astrocytes exposed to ammonia.9 Furthermore, most of the ammonia taken up by the brain is incorporated into glutamine via glutamine synthetase localized primarily in astrocytes. '0-12 In astrocyte cultures, glutamine synthesis is increased by elevated ammonia levels.'3 Inhibition of glutamine synthetase by methionine sulfoximine (MSO)14 prevents the increase in brain glutamine levels ordinarily seen with hyperammonemia15 and decreases mortality associated with acute ammonia toxicity. 16 We have shown that inhibition of glutamine synthetase activity by treatment with MSO prevented the increase in cortical water content in hyperammonemic rats. 6 Because MSO also prevented the 13 mmol/kg increase in tissue glutamine concentration, we suggested that accumulated glutamine may act as an idiogenic osmotic load. If this osmotic load is concentrated in the small astrocyte compartment, it may contribute to astrocyte swelling.
Because astrocyte foot processes surround the microvasculature, swollen astrocytes might contribute to abnormalities in cerebrovascular regulation either by direct compression or by alterations in interstitial fluid constituents.
In the present study, we tested whether abnormalities in the regional CBF responses to hypercapnia and hypocapnia occur during acute hyperammonemia in the rat as they do in the dog and cat and whether these abnormalities can be prevented by glutamine synthetase inhibition with MSO treatment. To assess CO2 specificity, we tested the response to an independent vasodilator stimulus, arterial hypotension. Furthermore, to determine if abnormal CO2 responses are a consequence of nonspecific effects of cerebral edema, we measured CBF responsivity to CO2 alterations during cerebral edema produced by hypoosmotic dextrose infusion.
Materials and Methods
Eighty-two male Wistar rats weighing 391+±24 g (mean±SD) were anesthetized with sodium pentobarbital (65 mg/kg i.p.). The lungs were mechanically ventilated through a tracheostomy with approximately 30% 02. Polyethylene catheters (PE-50) were inserted into the tail artery for measuring arterial blood pressure, into the abdominal aorta via the right femoral artery for obtaining the microsphere reference sample, into the right femoral vein for blood replacement, and into the right external jugular vein for infusion of solutions. Another polyethylene catheter (PE-10) was inserted into the left cardiac ventricle via the right subclavian artery for injection of microspheres. The pressure tracing was used to judge the distance to the aortic valve, and the catheter was advanced approximately 5 mm beyond that point. Left ventricular pressure tracings were verified before microsphere injection. In some rats, a small catheter (PE-10) was inserted approximately 1 mm into the cisterna magna CSF space after retracting overlying skin and muscle. Arterial and CSF pressure were recorded continuously throughout the experiment. Rectal temperature was maintained at 37°C with a water-circulating blanket. After completion of the surgery, pancuronium bromide (0.1 mg/kg i.v.) was administered. Additional pentobarbital (20 mg/kg i.p.) was injected every 1.5 hours. The last injection was timed to precede the blood flow determinations at the end of the protocol by at least 45 minutes. Before anesthesia and 3 hours before salt infusion, rats were pretreated with either L-methionine sulfoximine (MSO) (150 mg/kg i.p., Sigma Chemical Co., St. Louis, Mo.) or vehicle (1 ml/kg sterile water). We have found that this dose and timing reliably produces 64+4% (mean±+SD) inhibition of cortical glutamine synthetase activity and prevents the increase in tissue glutamine and water content in this hyperammonemic model. 6 Others have also observed similar inhibition of enzyme activity and glutamine accumulation with this dose of MSO.10,"5 16 At least 15 minutes after completing the surgery, rats received one of three continuous intravenous infusions. In a control group pretreated with vehicle (group 1), the infusate consisted of 200 mM sodium acetate in water for 30 minutes followed by 200 mM sodium acetate dissolved in 200 mM hydrochloric acid (HCl) for 340 minutes. The infusion rate was 0.1 ml/min, resulting in delivery of 52±3 ,Lmol * min`* kg-1 sodium acetate. Without the addition of HCl to the infusate, we observed severe metabolic alkalosis (arterial pH, 7.7) and an attenuated CBF response to CO2. In another control group pretreated with MSO (group 2), rats received the same infusion dose of sodium acetate and HCl as group 1. In a hyperammonemic group pretreated with vehicle (group 3), rats received 200 mM ammonium acetate in water at 0.1 ml/min (51±3 gmol * min-. kg-1) for 370 minutes. This infusion dose and duration were the same as previously used to produce cerebral edema.6 In a hyperammonemic group pretreated with MSO (group 4), ammonium acetate was infused as in group 3. To produce hyposmolarity (group 5), a solution of 2.5% dextrose was infused at a rate of 1.1 ml/min for 30 minutes followed by a maintenance rate of 0.78 ml/min for 40 minutes. Arginine vasopressin (1 pg * kg-1 . min-1) was infused simultaneously to reduce diuresis.
In groups 1-4, arterial blood samples (1 ml) were drawn at baseline and at 2 and 6 hours of salt infusion for analysis of plasma ammonia, plasma osmolarity, pH, partial pressures of CO2 (Pco2) and 02 (Po2), hemoglobin, and 02 content. In group 5, blood samples were drawn at baseline and at 1 hour of dextrose infusion for the same analyses (except ammonia). After obtaining the blood sample at 6 hours in groups 1-4 and at 1 hour in group 5, the first blood flow measurement was made under normocapnic conditions. Hypercapnia then was produced by ventilation with 8% CO2 in air. Arterial blood gases and blood flow were determined at 10 minutes of hypercapnia. In a separate experimental series of rats, hypocapnia was produced instead of hypercapnia. Hypocapnia was produced for 10 minutes by increasing the ventilation rate. In the hypercapnic series, the number of rats in groups 1-5 was 8, 6, 7, 9, and 9, respectively. In the hypocapnic series, the number in groups 1-5 was 7, 8, 8, 8, and 6, respectively.
In a separate group of six rats, hyperammonemia was produced by ammonium acetate infusion for 6 hours as in group 3 above. After obtaining a blood flow measurement at normotension, blood was withdrawn to reduce mean arterial pressure to approximately 50 mm Hg. Blood flow measurements were repeated approximately 5 minutes after pressure was stabilized at the reduced level.
Plasma ammonia was measured on a 50-,ul aliquot of plasma by a cation exchange-visible spectrophotometric technique previously described.17 Plasma was withdrawn from the abdominal aorta at a rate of 0.68 ml/min starting 0.5 minutes before the microsphere injection and ending 1.5 minutes after the injection was completed. Heparinized blood from a donor rat was transfused into the femoral vein at 0.68 ml/min simultaneously with the arterial reference withdrawal. At the end of the experiment, the heart was arrested by potassium chloride injection. The brain was removed and divided into cerebrum, diencephalon, midbrain, medulla plus pons, cerebellum, and cervical spinal cord. Kidneys were also harvested. Radioactivity in tissue and reference blood samples was measured in a gamma scintillation counter, and counts were corrected for spectral overlap of isotopes.18 Blood flow was calculated as the product of corrected tissue counts and the arterial reference withdrawal rate divided by counts in the arterial reference sample. There was no significant bias in the distribution of microspheres to the left versus right kidney or to the left versus right cerebrum. The absolute value of the percentage difference between the two kidneys was 6.8+10.8% (mean±SD), and the absolute difference between the two cerebral hemispheres was 11.1±10.7%. Cerebral perfusion pressure was calculated as the difference between mean arterial pressure and CSF pressure. Cerebrovascular resistance was calculated as cerebral perfusion pressure divided by blood flow to the cerebral hemispheres. All data were subjected to two-way analysis of variance (ANOVA) for effect of treatment between groups and for repeated measures within groups. If there was a significant effect of treatment or an interaction between treatment and time, one-way ANOVA between treatment groups was performed at each time point, and mean values were compared by the Newman-Keuls multiple-range test. If there was a significant effect of repeated measures of any of the blood analyses, mean values were compared with the baseline values by Dunnett's test. For hemodynamic measurements, comparisons between either the hypercapnic or hypocapnic value and the respective normocapnic value were made by preplanned paired t tests when two-way ANOVA indicated a significant effect of time. Except where noted, all values are presented at mean±SEM, and values of p<0.05 were considered significant.
Results

Hypercapnic Experiments
With sodium acetate plus HCl infusion, plasma ammonia levels (Table 1) remained at or below baseline levels in rats pretreated with vehicle (group 1, 27±3 gmol/l) and with MSO (group 2, 55±8 ,umol/l). With ammonium acetate infusion, plasma ammonia levels increased in rats pretreated with vehicle (group 3, 534±45 ,umol/l) and with MSO (group 4, 666+43 gmol/l). The values at 6 hours of infusion when the normocapnic CBF measurements were made were similar to those at 2 hours, thereby indicating a relative steady state of plasma ammonia levels. Plasma osmolarity was unchanged in groups 1 and 2 but decreased in groups 3 and 4 with ammonium acetate infusion (Table  1 ). With infusion of hypoosmotic dextrose (group 5), plasma osmolarity decreased to 255+2 mosm/l, which was significantly lower than that in the other four groups.
Arterial pH and Pco2 were maintained within normal physiological limits during salt infusion in groups 1-4, but pH decreased in group 5. The hypercapnic chal-groups (mean value, 64-70 mm Hg) except for a greater value in group 5 (81 mm Hg). Arterial hemoglobin concentration and 02 content decreased during the infusion in all groups, but the decrease was greater in sodium acetate and hyposmotic dextrose groups than in the hyperammonemic groups (Table 1) .
Mean arterial blood pressure decreased during hypercapnia, but the levels were greater in groups 3 and 5 than in the other groups (Table 2 ). Cisterna magna CSF pressure measured in subsets of rats was significantly elevated in hyperammonemic rats untreated with MSO (group 3) and in hyposmotic rats (group 5) during both normocapnia and hypercapnia. In hyperammonemic rats treated with MSO (group 4), CSF pressure was similar to sodium acetate-treated control rats ( Table 2) .
During normocapnia, CBF was not significantly different among groups (p<0.15 by ANOVA). During hypercapnia, CBF increased in all rats receiving sodium acetate plus HCI infusion whether they were pretreated with vehicle or MSO ( Figure 1 ). With ammonium acetate infusion and vehicle pretreatment, CBF decreased in five of seven rats and increased by only 22% and 33% in two rats; thus, CBF was not significantly changed during hypercapnia. However, with MSO pretreatment, CBF increased in eight of nine hyperammonemic rats, and the increase was significant. In hypoosmotic group 5 rats, CBF was unchanged during hypercapnia. The levels of CBF during hypercapnia were significantly less in groups 3 and 5 than in the other groups.
Although arterial pressure decreased during hypercapnia, analysis of cerebrovascular resistance reflected the same statistical differences as CBF data. Resistance decreased significantly in groups 1, 2, and 4 but not in groups 3 and 5 during hypercapnia ( Figure 2 ). The resistance values during hypercapnia in groups 3 and 5 were significantly greater than those in other groups. There was no difference in resistance values among groups during normocapnia. Table 3 , hypercapnic blood flow responses in the diencephalon, midbrain, medulla plus pons, and cerebellum were similar to the response in the cerebrum in that blood flow increased significantly in hyperammonemic rats treated with MSO (group 4) but not in those not treated with MSO (group 3). In the cerebellum, blood flow was significantly elevated during normocapnia in group 3 and decreased during hypercapnia. In group 5, the blood flow response to hypercapnia was attenuated in all brain regions. In the spinal cord, blood flow increased in all groups, although flow was less in both hyperammonemic groups than in the control groups.
As shown in
Hypocapnic Experiments
The changes in arterial plasma ammonia, osmolarity, pH, blood gases, hemoglobin, and 02 content during the infusion period in the five groups studied in the hypocapnic experiment (Table 4 ) were similar to those described for the corresponding groups in the hypercapnic experiment. With hyperventilation, there was no difference among groups in the level of arterial Pco2 (mean values, 15-19 mm Hg). There was also no significant difference among groups in other blood measurelenge resulted in similar levels of arterial Pco2 among ments aside from an elevated arterial P02 in group 5. Mean arterial pressure during hypocapnia was unchanged from normocapnic values in groups 1-3 (Table  5 ). In group 4, pressure increased during hypocapnia, but the level was similar to the levels in groups 1-3. In hypoosmotic group 5, pressure was higher than that in the other groups. Cisterna magna CSF pressure was (Figure 3 ). In contrast, CBF increased during hypocapnia in hyperammonemic rats treated with vehicle, and the level of CBF exceeded the levels in the other groups. In hyperammonemic rats treated with MSO, CBF was unchanged during hypocapnia, but the level of CBF did not differ from that in group 1. In the hyposmotic rats (group 5), CBF decreased during hypocapnia.
Statistical analysis of cerebrovascular resistance data was consistent with that of CBF data. Resistance significantly increased during hypocapnia in groups 1, 2, and 5 but decreased in hyperammonemic rats in group 3 (Figure 4 ). The level of cerebrovascular resistance during hypocapnia in group 3 was less than that in all other groups, including the MSO-pretreated hyperammonemic rats in group 4. Resistance in group 4 was not significantly changed during hypocapnia.
Paradoxical increases in blood flow during hypocapnic hyperammonemia also occurred in the diencephalon and midbrain, and these increases were also inhibited by MSO pretreatment (Table 6 ). In the cerebellum and medulla plus pons, blood flow was unchanged during hypocapnia in both hyperammonemic groups (3 and 4) . In the spinal cord, blood flow decreased in group 3 but not in group 4, although the level in group 4 did not differ from the levels in the other hypocapnic groups. In group 5, blood flow decreased in all brain regions.
In the dextrose-treated hyposmotic rats, fractional water content of cortical gray matter measured at the end of the experiment was 0.838+0.005 in group 5 of the hypercapnic experiment and 0.835 +0.004 in group 5 of the hypocapnic experiment. In our previous study,6 cortical water content values in rats treated similarly to those of groups 1-4 were 0.783+0.003, 0.782+0.004, 0.804+0.003, and 0.784+0.005, respectively. These values were lower than those of group 5 in the present study.
Hypotension Experiments
In six rats subjected to 6 hours of elevated plasma ammonia (533+24 ,umol/l), mean arterial pressure was reduced from 108+4 to 48±2 mm Hg. CBF was not significantly changed (from 78±9 to 70±8 ml/min per 100 g). Cerebrovascular resistance decreased by 48 + 8%.
Discussion
The results of this study demonstrate 1) that 6 hours of elevated plasma ammonia levels (approximately 600 ,M) in the rat cause complete loss of the CBF response to hypercapnia and a paradoxical increase in CBF during hypocapnia, 2) that pretreatment with MSO did not affect CBF responsivity to hypercapnia or hypocapnia in control rats but largely restored CBF responses to hypercapnia and prevented the paradoxical decrease in CBF during hypocapnia in hyperammonemic rats, 3) that changes in CBF responsivity in both vehicle-and MSO-treated hyperammonemic groups were mirrored by reciprocal changes in cerebrovascular resistance, 4) that cerebral edema and elevated CSF pressure produced by hyposmolarity caused loss of CBF responsivity to hypercapnia but, unlike hyperammonemia, did not cause a loss of CBF responsivity to hypocapnia, and 5) that loss of hypercapnic responsivity is specific for CO2 because vascular resistance decreased with hemorrhagic hypotension. These results implicate mechanisms linked to glutamine accumulation in the abnormal CBF responsivity to CO2 during hyperammonemia.
We previously found that increased cortical water content and decreased tissue specific gravity during hyperammonemia were prevented by MSO pretreatment. 6 Furthermore, hyperammonemia caused an increase in cortical glutamine levels of 13 mmol/kg that was also prevented by MSO pretreatment. Because ammonia causes astrocyte swelling3'7'9 and astrocytes are enriched in glutamine synthetase,12 we speculated that glutamine accumulation may cause astrocyte swelling by increasing intracellular osmoles. In the present study with a similar level and duration of hyperammonemia, CSF pressure was elevated in the hyperammonemic group treated with vehicle but not in the groups treated with MSO. The latter finding supports our hypothesis of glutamine accumulation as a mechanism of cerebral edema.
Restoration of the CBF response to hypercapnia during hyperammonemia by MSO treatment may be related to prevention of cerebral edema and elevated CSF pressure. In support of this hypothesis, cerebral edema and elevated CSF pressure produced by hyposmolarity also abolished the CBF response to hypercapnia. However, there are three reasons why cerebral edema is unlikely to completely account for the abolished response. First, with cerebral perfusion pressure during hypercapnia in group 3 hyperammonemic rats estimated as mean arterial pressure (89 mm Hg) minus cisternal CSF pressure (16 mm Hg) , the perfusion pressure value of 73 mm Hg is not sufficiently low to explain the complete loss of CO2 reactivity based on other models of reduced perfusion pressure.1920 Although supratentorial CSF pressure might exceed CSF pressure measured in the cisterna magna, blood flow responses in infratentorial brain regions were also abnormal. Moreover, cerebrovascular resistance during hypercapnia in group 3 hyperammonemic rats exceeded that in control rats, thereby suggesting that the diminished CBF response was not attributable to maximal vasodilation. Second, with hemorrhagic hypotension, CBF was unchanged as a result of a large decrease in cerebrovascular resistance. This observation is in agreement with that in hyperammonemic cats.2 Thus, cerebral vessels vessels by swollen cells may partly contribute to impaired responsivity to hypercapnia, compression is unlikely to provide a complete explanation for loss of CO2 responsivity or for the paradoxical increase in CBF and decrease in vascular resistance during hypocapnia. Alternatively, hyperammonemia is known to produce selective swelling of astrocytes, including foot processes and surrounding vessels, whereas hyposmolarity presumably produces swelling in all cell types. If foot process swelling is greater with hyperammonemia than with hyposmolarity and if swelling changes dynamically with changes in Pco2 but not with hypotension during hyperammonemia, then the mechanical effect of astrocyte swelling could be underestimated by measures of total tissue water content and CSF pressure.
Several other explanations of how CBF responsivity to CO2 may be linked to glutamine accumulation warrant consideration. First, astrocyte swelling may lead to abnormal control of extracellular K' and pH, which in turn affect vascular tone. For example, astrocytes ordinarily exert tight control of extracellular K' activity,21 and K' conductance appears selectively greater at endfoot processes.22 Elevated K' activity with high ammonia levels23,24 may be the result of astrocyte dysfunction. The combination of hypocapnia and less severe hyperammonemia in the present experiments may increase extracellular K' activity and prevent hypocapnic vasoconstriction. In addition, astrocytes are enriched in carbonic anhydrase,25,26 which may be linked to proton and bicarbonate antiporters. With changes in Pco2, the transcellular proton gradient may be disturbed, and extracellular pH surrounding arterioles may be affected differently during hyperammonemia. In these cases, partial restoration of CBF responsivity to CO2 by MSO could be due to improved astrocyte control of extracellular ion concentration. A second explanation is that hyperammonemia alters energy metabolism. After 48 hours of hyperammonemia, cerebral glucose consumption is reduced, and this reduction is well correlated with glutamine accumulation. 27 Although reduced metabolism may contribute to reduced vascular CO2 responsivity, it is probably not the major mechanism, because reduced CO2 responsivity observed in hyperammonemic dogs occurred without a depression of cerebral 02 consumption'.'
A third possibility is that ammonia exerts direct effects on cerebral vessels independent of astrocytes. High ammonia levels in the millimolar range cause relaxation in isolated vessels presumably by altering intracellular pH. 21 29 However, changes in smooth muscle intracellular pH with the submillimolar ammonia levels used in the present study are probably small, and it is unclear how MSO would act to restore intracellular pH.
A fourth possibility is that glutamine exerts direct effects on vascular reactivity. With arginine depletion in the aorta, glutamine inhibits the release of endothelial relaxing factor.3031 Although arginine is not ordinarily rate limiting for nitric oxide generation, it is possible that under hyperammonemic conditions increases in interstitial glutamine32 modulate endothelium-dependent responses and, in turn, modulate CO2 reactivity.
Another explanation is that MSO exerts direct effects on vascular reactivity. Although glutamine synthetase activity is much less in brain microvessels than whole brain,33 it might affect amino acid transport. In addition to inhibiting glutamine synthetase, MSO inhibits synthesis of y-glutamylcysteine, a precursor of glutathione. 34 However, MSO does not reduce brain glutathione levels,35 and a decrease in this antioxidant is unlikely to restore vascular reactivity. y-Glutamylcysteine synthetase is part of the y-glutamyl cycle, which is thought to be involved in amino acid transport in cerebral microvessels.3637 However, MSO treatment in control rats receiving sodium acetate did not significantly affect CBF responsivity. Thus, for MSO to restore CBF responsivity during hyperammonemia by inhibiting y-glutamylcysteine synthetase, ammonia would need to cause some alteration in the y-glutamyl cycle that would affect vascular reactivity. We are not aware of any clear data in the literature to support such a mechanism. Nevertheless, normocapnic CBF tended to be less in hyperammonemic rats pretreated with MSO (p<0.15), and we cannot completely exclude some other nonspecific effect of MSO on vascular reactivity.
We believe that the most likely explanations, based on the foregoing discussion, for ammonia-induced abnormalities in CO2 responsivity are astrocyte dysfunction in controlling extracellular ions or some abnormality linked to glutamine metabolism that affects vascular reactivity. Ammonia-induced cerebral edema may also act to restrict increases in CBF during hypercapnia but is unlikely to fully account for loss of CBF responsivity.
Alterations in CO2 responses are not readily explained by other physiological parameters such as arterial pressure or 02 content. Although mean arterial pressure decreased in all groups during hypercapnia, the decrease was less in the hyperammonemic group with vehicle pretreatment (Table 2) . Thus, the higher arterial pressure would not explain the lower CBF responses. Moreover, hyperammonemia did not abolish the autoregulatory response at a level of arterial hypotension more severe than that occurring during hypercapnia. Furthermore, differences in the cerebrovascular resistance responses during hypercapnia among groups were congruent with differences in the CBF responses. Infusion of the salt solutions caused some hemodilution, and subsequent hypercapnia caused some arterial 02 desaturation as a result of the Bohr effect. However, the decrease in arterial 02 content was greater in the sodium acetate groups than in the ammonium acetate groups (Table 1) . Thus, loss of CO2 responsivity during hyperammonemia is not attributable to greater hypoxemia. In the hypocapnic experiments, arterial 02 content values were similar among groups. Mean arterial pressure was unchanged with hypocapnia except in the hyperammonemic group treated with MSO. Although the increase in arterial pressure in the latter group may have counteracted the hypocapnic-induced reductions in CBF, the increase in pressure was relatively small, and cerebrovascular resistance was not significantly changed. Thus, changes in arterial pressure and 02 content were not major confounding factors.
Hyperammonemia did not cause a significant change in normocapnic levels of CBF, which could account for changes in CO2 responsivity. However, normocapnic blood flow in the cerebellum was double that of control rats. Elevated cerebellar blood flow may have acted to attenuate the response to hypercapnia, but it would not account for loss of the response to hypocapnia. The mechanism of increased flow appears to be related to glutamine metabolism, because elevated cerebellar blood flow was not observed with MSO treatment in hyperammonemic rats. Elevated cerebellar blood flow was not observed in hyperammonemic dogs, but midbrain blood flow was selectively increased in dogs, particularly when metabolic alkalemia acted to increase ammonia influx into the brain.',38 Although these results suggest some species differences, the studies are not strictly comparable because the severity of normocapnic hyperammonemia was greater and the duration was shorter in the dog than in the rat. Analysis of autopsied tissue from patients who died from hepatic coma indicated elevations of glutamine levels in all brain regions, including the cerebellum and brainstem. 39 We found that loss of CO2 responsivity was not specific for the cerebral cortex but also occurred in the diencephalon, brainstem, and cerebellum. On a regional basis, the most marked increase in blood flow during hypocapnia was in the midbrain, where blood flow doubled. This result agrees with the results in hyperammonemic dogs, in which loss of hypocapnic responsivity occurred throughout the brain and in which paradoxical increases in blood flow were most pronounced in the midbrain.' Others have shown loss of hypercapnic responses in the cerebrum of cats2 at plasma ammonium levels similar to those in the present study on rats. Likewise, hypercapnic responsivity of internal carotid artery blood flow in hyperammonemic monkeys40 and of internal maxillary artery blood flow in carbon tetrachloride-induced liver disease in goats4' is depressed. Thus, abnormalities in cerebrovascular CO2 responsivity during hyperammonemia do not appear to be species specific.
The spinal cord was the only central nervous system region in which CO2 responsivity was intact during hyperammonemia. Although we did not measure glutamine or water content in the spinal cord, elevated glutamine levels have been reported in the spinal cord of rats with portocaval anastomosis. 42 We also found that spinal cord blood flow responses to CO2 were intact with hyposmolarity. Perhaps the large surface area to volume ratio of the long cylindrical spinal cord permits swelling with less compression of blood vessels. Thus, preservation of CO2 responses in the spinal cord during hyperammonemia may be related either to less swelling in the spinal cord or to less impact of the swelling on blood flow responsivity. Alternatively, abnormalities in CO2 responses secondary to astrocyte dysfunction may be related to the involvement of astrocytes in the synaptic glutamate-glutamine cycle, which is more prominent in the brain than the cervical spinal cord with large white-matter tracts.
In summary, results from our study demonstrate that abnormal CBF responses to CO2 during hyperammonemia are linked to glutamine synthesis and accumulation rather than ammonia per se. Although mechanical effects of astrocyte swelling may contribute to the abnormal CBF responses during hypercapnia, a more fundamental abnormality in astrocyte function affecting vascular control is likely. Thus, hyperammonemia may represent a unique experimental condition for evaluating the role of astrocytes on cerebrovascular control.
